Effect of sequence variation in meningococcal PorA outer membrane protein on the effectiveness of a hexavalent PorA outer membrane vesicle vaccine in toddlers and school children

This publication has 24 references indexed in Scilit:

• Meningococcal conjugate vaccine for Africa: a model for development of new vaccines for the poorest countries
  The Lancet, 2003
• Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis
  BMJ, 2003
• Safety, Reactogenicity, and Immunogenicity of a Tetravalent Meningococcal Polysaccharide–Diphtheria Toxoid Conjugate Vaccine Given to Healthy Adults
  The Journal of Infectious Diseases, 2002
• Impact of meningococcal C conjugate vaccine in the UK
  Journal of Medical Microbiology, 2002
• N-Propionylated Group B Meningococcal Polysaccharide Mimics a Unique Bactericidal Capsular Epitope in Group B Neisseria meningitidis
  The Journal of Experimental Medicine, 1997
• Preclinical Evaluation of a Novel Group B Meningococcal Conjugate Vaccine that Elicits Bactericidal Activity in both Mice and Nonhuman Primates
  The Journal of Infectious Diseases, 1997
• Protective efficacy of a serogroup B meningococcal vaccine in Sao Paulo, Brazil
  The Lancet, 1992
• Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway
  The Lancet, 1991
• ANTIGENIC SIMILARITIES BETWEEN BRAIN COMPONENTS AND BACTERIA CAUSING MENINGITIS
  The Lancet, 1983
• Immunologic Response of Man to Group B Meningococcal Polysaccharide Vaccines
  The Journal of Infectious Diseases, 1972